La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD

Identifieur interne : 001D22 ( Main/Exploration ); précédent : 001D21; suivant : 001D23

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD

Auteurs : T. Van Eimeren [Canada] ; G. Pellecchia [Canada] ; R. Cilia [Canada] ; B. Ballanger [Canada] ; T. D. L. Steeves [Canada] ; S. Houle [Canada] ; J. M. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; A. P. Strafella [Canada]

Source :

RBID : Pascal:11-0003745

Descripteurs français

English descriptors

Abstract

Objective: Some patients with Parkinson disease (PD) develop pathological gambling when treated with dopamine agonists (DAs). However, little is known about DA-induced changes in neuronal networks that may underpin this drug-induced change in behavior in vulnerable individuals. In this case-control study, we aimed to investigate DA-induced changes in brain activity that may differentiate patients with PD with DA-induced pathological gambling (gamblers) from patients with PD without such a history (controls). Methods: Following overnight withdrawal of antiparkinsonian medication, patients were studied with H215O PET before and after administration of DA (3 mg apomorphine) to measure changes in regional cerebral blood flow as an index of regional brain activity during a card selection game with probabilistic feedback. Results: We observed that the direction of DA-related activity change in brain areas that are implicated in impulse control and response inhibition (lateral orbitofrontal cortex, rostral cingulate zone, amygdala, external pallidum) distinguished gamblers from controls. DA significantly increased activity in these areas in controls, while gamblers showed a significant DA-induced reduction of activity. Conclusions: We propose that in vulnerable patients with PD, DAs produce an abnormal neuronal pattern that resembles those found in nonparkinsonian pathological gambling and drug addiction. DA-induced disruption of inhibitory key functions-outcome monitoring (rostral cingulate zone), acquisition and retention of negative action-outcome associations (amygdala and lateral orbitofrontal cortex)-together with restricted access of those areas to executive control (external pallidum)-may well explain loss of impulse control and response inhibition in vulnerable patients with PD, thereby fostering the development of pathological gambling.

Url:


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD</title>
<author>
<name sortKey="Van Eimeren, T" sort="Van Eimeren, T" uniqKey="Van Eimeren T" first="T." last="Van Eimeren">T. Van Eimeren</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Pellecchia, G" sort="Pellecchia, G" uniqKey="Pellecchia G" first="G." last="Pellecchia">G. Pellecchia</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Cilia, R" sort="Cilia, R" uniqKey="Cilia R" first="R." last="Cilia">R. Cilia</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Ballanger, B" sort="Ballanger, B" uniqKey="Ballanger B" first="B." last="Ballanger">B. Ballanger</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Steeves, T D L" sort="Steeves, T D L" uniqKey="Steeves T" first="T. D. L." last="Steeves">T. D. L. Steeves</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Houle, S" sort="Houle, S" uniqKey="Houle S" first="S." last="Houle">S. Houle</name>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Miyasaki, J M" sort="Miyasaki, J M" uniqKey="Miyasaki J" first="J. M." last="Miyasaki">J. M. Miyasaki</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zurowski, M" sort="Zurowski, M" uniqKey="Zurowski M" first="M." last="Zurowski">M. Zurowski</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Strafella, A P" sort="Strafella, A P" uniqKey="Strafella A" first="A. P." last="Strafella">A. P. Strafella</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0003745</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 11-0003745 INIST</idno>
<idno type="RBID">Pascal:11-0003745</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000358</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000905</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000365</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000365</idno>
<idno type="wicri:doubleKey">0028-3878:2010:Van Eimeren T:drug:induced:deactivation</idno>
<idno type="wicri:Area/Main/Merge">001E55</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033606</idno>
<idno type="RBID">PMC:3033606</idno>
<idno type="wicri:Area/Pmc/Corpus">000322</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000322</idno>
<idno type="wicri:Area/Pmc/Curation">000322</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000322</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000A51</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000A51</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">000C89</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C89</idno>
<idno type="wicri:Area/PubMed/Curation">000C89</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C89</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000C89</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C89</idno>
<idno type="wicri:Area/Ncbi/Merge">000D51</idno>
<idno type="wicri:Area/Ncbi/Curation">000D51</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D51</idno>
<idno type="wicri:doubleKey">0028-3878:2010:Van Eimeren T:drug:induced:deactivation</idno>
<idno type="wicri:Area/Main/Merge">001B68</idno>
<idno type="wicri:Area/Main/Curation">001D22</idno>
<idno type="wicri:Area/Main/Exploration">001D22</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD</title>
<author>
<name sortKey="Van Eimeren, T" sort="Van Eimeren, T" uniqKey="Van Eimeren T" first="T." last="Van Eimeren">T. Van Eimeren</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Pellecchia, G" sort="Pellecchia, G" uniqKey="Pellecchia G" first="G." last="Pellecchia">G. Pellecchia</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Cilia, R" sort="Cilia, R" uniqKey="Cilia R" first="R." last="Cilia">R. Cilia</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Ballanger, B" sort="Ballanger, B" uniqKey="Ballanger B" first="B." last="Ballanger">B. Ballanger</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Steeves, T D L" sort="Steeves, T D L" uniqKey="Steeves T" first="T. D. L." last="Steeves">T. D. L. Steeves</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Houle, S" sort="Houle, S" uniqKey="Houle S" first="S." last="Houle">S. Houle</name>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Miyasaki, J M" sort="Miyasaki, J M" uniqKey="Miyasaki J" first="J. M." last="Miyasaki">J. M. Miyasaki</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zurowski, M" sort="Zurowski, M" uniqKey="Zurowski M" first="M." last="Zurowski">M. Zurowski</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Strafella, A P" sort="Strafella, A P" uniqKey="Strafella A" first="A. P." last="Strafella">A. P. Strafella</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Division of Brain, Imaging and Behaviour-Systems Neuroscience, BIB-SN Toronto Western Research Institute</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Movement Disorders Centre Toronto Western Hospital</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Movement Disorders Centre Toronto Western Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="03">
<s1>CAMH-PET Centre University of Toronto</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Frontal Lobe (drug effects)</term>
<term>Frontal Lobe (physiology)</term>
<term>Gambling (diagnosis)</term>
<term>Gambling (psychology)</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Nerve Net (drug effects)</term>
<term>Nerve Net (physiology)</term>
<term>Nervous system diseases</term>
<term>Neural Inhibition (drug effects)</term>
<term>Neural Inhibition (physiology)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (psychology)</term>
<term>Pathological gambling</term>
<term>Photic Stimulation (methods)</term>
<term>Positron-Emission Tomography (methods)</term>
<term>Predictive Value of Tests</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Gambling</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Frontal Lobe</term>
<term>Nerve Net</term>
<term>Neural Inhibition</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Photic Stimulation</term>
<term>Positron-Emission Tomography</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Frontal Lobe</term>
<term>Nerve Net</term>
<term>Neural Inhibition</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Gambling</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Predictive Value of Tests</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Jeu pathologique</term>
<term>Pathologie du système nerveux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Objective: Some patients with Parkinson disease (PD) develop pathological gambling when treated with dopamine agonists (DAs). However, little is known about DA-induced changes in neuronal networks that may underpin this drug-induced change in behavior in vulnerable individuals. In this case-control study, we aimed to investigate DA-induced changes in brain activity that may differentiate patients with PD with DA-induced pathological gambling (gamblers) from patients with PD without such a history (controls). Methods: Following overnight withdrawal of antiparkinsonian medication, patients were studied with H
<sub>2</sub>
<sup>15</sup>
O PET before and after administration of DA (3 mg apomorphine) to measure changes in regional cerebral blood flow as an index of regional brain activity during a card selection game with probabilistic feedback. Results: We observed that the direction of DA-related activity change in brain areas that are implicated in impulse control and response inhibition (lateral orbitofrontal cortex, rostral cingulate zone, amygdala, external pallidum) distinguished gamblers from controls. DA significantly increased activity in these areas in controls, while gamblers showed a significant DA-induced reduction of activity. Conclusions: We propose that in vulnerable patients with PD, DAs produce an abnormal neuronal pattern that resembles those found in nonparkinsonian pathological gambling and drug addiction. DA-induced disruption of inhibitory key functions-outcome monitoring (rostral cingulate zone), acquisition and retention of negative action-outcome associations (amygdala and lateral orbitofrontal cortex)-together with restricted access of those areas to executive control (external pallidum)-may well explain loss of impulse control and response inhibition in vulnerable patients with PD, thereby fostering the development of pathological gambling.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Van Eimeren, T" sort="Van Eimeren, T" uniqKey="Van Eimeren T" first="T." last="Van Eimeren">T. Van Eimeren</name>
</noRegion>
<name sortKey="Ballanger, B" sort="Ballanger, B" uniqKey="Ballanger B" first="B." last="Ballanger">B. Ballanger</name>
<name sortKey="Ballanger, B" sort="Ballanger, B" uniqKey="Ballanger B" first="B." last="Ballanger">B. Ballanger</name>
<name sortKey="Cilia, R" sort="Cilia, R" uniqKey="Cilia R" first="R." last="Cilia">R. Cilia</name>
<name sortKey="Cilia, R" sort="Cilia, R" uniqKey="Cilia R" first="R." last="Cilia">R. Cilia</name>
<name sortKey="Houle, S" sort="Houle, S" uniqKey="Houle S" first="S." last="Houle">S. Houle</name>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name>
<name sortKey="Miyasaki, J M" sort="Miyasaki, J M" uniqKey="Miyasaki J" first="J. M." last="Miyasaki">J. M. Miyasaki</name>
<name sortKey="Pellecchia, G" sort="Pellecchia, G" uniqKey="Pellecchia G" first="G." last="Pellecchia">G. Pellecchia</name>
<name sortKey="Pellecchia, G" sort="Pellecchia, G" uniqKey="Pellecchia G" first="G." last="Pellecchia">G. Pellecchia</name>
<name sortKey="Steeves, T D L" sort="Steeves, T D L" uniqKey="Steeves T" first="T. D. L." last="Steeves">T. D. L. Steeves</name>
<name sortKey="Strafella, A P" sort="Strafella, A P" uniqKey="Strafella A" first="A. P." last="Strafella">A. P. Strafella</name>
<name sortKey="Strafella, A P" sort="Strafella, A P" uniqKey="Strafella A" first="A. P." last="Strafella">A. P. Strafella</name>
<name sortKey="Strafella, A P" sort="Strafella, A P" uniqKey="Strafella A" first="A. P." last="Strafella">A. P. Strafella</name>
<name sortKey="Van Eimeren, T" sort="Van Eimeren, T" uniqKey="Van Eimeren T" first="T." last="Van Eimeren">T. Van Eimeren</name>
<name sortKey="Zurowski, M" sort="Zurowski, M" uniqKey="Zurowski M" first="M." last="Zurowski">M. Zurowski</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D22 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D22 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:11-0003745
   |texte=   Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022